Publication:
A Microfluidic Platform for Rapid Isolation of Cells Based on Secretion of Antigen Specific Antibodies

No Thumbnail Available

Date

2017-09-13

Published Version

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Ding, Ruihua. 2017. A Microfluidic Platform for Rapid Isolation of Cells Based on Secretion of Antigen Specific Antibodies. Doctoral dissertation, Harvard University, Graduate School of Arts & Sciences.

Research Data

Abstract

Droplet microfluidics provides compartmentalization of cells into picoliter-sized droplets, enabling economical, sensitive and massively parallel biological assays. Droplets can be actively manipulated for different applications. In particular, droplet sorting allows rapid isolation of individual desired droplets from a large excess of undesired droplets. Droplet sorting is particularly powerful when combined with in-droplet assays to identify cells that secrete molecules of interest. However, the accuracy of droplet sorting is limited due to droplet coalescence. In this dissertation I present a droplet filter design that effectively separates droplets by size. The droplet filter has a sharp size cut-off and can distinguish droplets differing in volume by as little as 20%. A simple model explains the behaviour of the droplets as they pass through the filter. We apply the filter upstream of a droplet sorter and show it improves sorting efficiency. We also develop a droplet-based system to accurately identify and isolate individual cells that secrete antigen-specific antibodies. This system eliminates the inefficient and time-consuming steps of cell fusion and clonal expansion required in standard monoclonal antibody generation methods. I present use of this system, coupled with filter-improved droplet sorting, to isolate cells that secrete antigen-specific antibodies. The platform is capable of screening a million droplets within one day and is able to isolate rare antigen-specific cells that consist of 0.1% of the total population. We apply this system to frozen primary rat cells. After sorting, we perform single-cell RT-PCR to identify the IgG-encoding sequences from each isolated cell. A novel ELISA assay is used to verify the target-binding ability of the encoded IgG molecules.

Description

Other Available Sources

Keywords

Microfluidics, Antibody

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Referenced By

Related Stories